KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Amneal Pharmaceuticals (AMRX) Income from Non-Controlling Interests (2017 - 2025)

Amneal Pharmaceuticals has reported Income from Non-Controlling Interests over the past 9 years, most recently at $14.5 million for Q4 2025.

  • Quarterly results put Income from Non-Controlling Interests at $14.5 million for Q4 2025, up 40.22% from a year ago — trailing twelve months through Dec 2025 was $55.9 million (up 29.91% YoY), and the annual figure for FY2025 was $55.9 million, up 29.91%.
  • Income from Non-Controlling Interests for Q4 2025 was $14.5 million at Amneal Pharmaceuticals, down from $15.8 million in the prior quarter.
  • Over the last five years, Income from Non-Controlling Interests for AMRX hit a ceiling of $17.8 million in Q2 2023 and a floor of -$119.3 million in Q2 2022.
  • Median Income from Non-Controlling Interests over the past 5 years was $10.2 million (2024), compared with a mean of $923100.0.
  • Biggest five-year swings in Income from Non-Controlling Interests: crashed 776.0% in 2022 and later skyrocketed 5034.11% in 2023.
  • Amneal Pharmaceuticals' Income from Non-Controlling Interests stood at -$14.1 million in 2021, then soared by 89.17% to -$1.5 million in 2022, then skyrocketed by 447.87% to $5.3 million in 2023, then surged by 94.89% to $10.3 million in 2024, then skyrocketed by 40.22% to $14.5 million in 2025.
  • The last three reported values for Income from Non-Controlling Interests were $14.5 million (Q4 2025), $15.8 million (Q3 2025), and $13.2 million (Q2 2025) per Business Quant data.